摘要:
This invention relates to a method of treating gastric adenocarcinoma or lung carcinoma by administering to a subject in need thereof an effective amount of an effective amount of a diterpene compound of the following formula: wherein R1, R2, R3, R4, and R5 are defined herein.
摘要:
This invention relates to a method of treating cancer by administering to a subject in need thereof an effective amount of a chemotherapeutic agent and an effective amount of a diterpene compound of the following formula: wherein R1, R2, R3, R4, and R5 are defined herein.
摘要:
Compositions containing a Sophora flavescens flavonoids extract or its active ingredients, Kurarinone, 2′-methoxy-Kurarinone, and Sophoraflavanone G are described. Also disclosed is a method of treating TNFα and IL-1β related diseases using such compositions.
摘要:
This invention relates to a method of treating cancer by administering to a subject in need thereof an effective amount of a cancer chemotherapeutic agent and an effective amount of a benzoquinone compound of the following formula: wherein R1, R2, R3, and R4 are defined herein.
摘要:
This invention relates to a method of treating certain cancers by administering an effective amount of a compound of the following formula: wherein R1, R2, R3, and R4 are defined herein.
摘要:
Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).
摘要:
Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
摘要:
Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).
摘要:
Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
摘要:
Substituted quinazoline compounds of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and X are defined herein. It also discloses a pharmaceutical composition containing one of these compounds.